Entering text into the input field will update the search result below

FDA allows more pharmacists to prescribe Pfizer COVID antiviral Paxlovid

Jul. 06, 2022 1:18 PM ETPfizer Inc. (PFE)CVSBy: Jonathan Block, SA News Editor3 Comments

Province of Florence, Italy, 7th December 2021, close up of the pill anti covid by Pfizer, called Paxlovid.

Rafmaster/iStock via Getty Images

  • More pharmacists now have the ability to directly prescribe Pfizer's (NYSE:PFE) COVID-19 antiviral Paxlovid in certain situations.
  • The U.S. FDA has amended the Emergency Use Authorization for Paxlovid (nirmatrelvir and ritonavir) to allow state-licensed pharmacists to prescribe the

Recommended For You

Comments (3)

Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

MickeyD77 profile picture
I wonder if this will also allow use of the Merck drug for Covid. It seems to have fewer drug interactions and is being used more frequently than the Pfizer drug.
Did Pfizer approved of this FDA decision?
There are criteria in order to get prescribed and if you qualify and of course your physician writes prescription it is a worthy option to consider. Hats off to the entire medical community (particularly Pfizer, Medicare, CVS) for outstanding work and availability. U.S. is so far ahead in CV19 treatments and overall network battling a disease that will be with us longer than we previously thought. Keep in home test kits available and do your due diligence by researching options in treating early onset of disease. Good luck to all.

About PFE

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
Pfizer Inc.
AstraZeneca PLC
Roche Holding AG
Bristol-Myers Squibb Company
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.